Publikationen, an denen er mitarbeitet Daniel Plano Amatriain (89)

2024

  1. Biomaterials-Based Antioxidant Strategies for the Treatment of Oxidative Stress Diseases

    Biomimetics, Vol. 9, Núm. 1

  2. Following the Trace of Cyclodextrins on the Selenium and Tellurium Odyssey

    International Journal of Molecular Sciences, Vol. 25, Núm. 14

  3. Formulation Studies with Cyclodextrins for Novel Selenium NSAID Derivatives

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

  4. Novel Pitolisant-Derived Sulfonyl Compounds for Alzheimer Disease

    International Journal of Molecular Sciences, Vol. 25, Núm. 2

  5. Selenization of Small Molecule Drugs: A New Player on the Board

    Journal of Medicinal Chemistry, Vol. 67, Núm. 10, pp. 7759-7787

  6. Seleno-Warfare against Cancer: Decoding Antitumor Activity of Novel Acylselenoureas and Se-Acylisoselenoureas

    Pharmaceutics, Vol. 16, Núm. 2

  7. Thermal characterization, polymorphism, and stability evaluation of Se-NSAID derivatives with potent anticancer activity

    Journal of Thermal Analysis and Calorimetry, Vol. 149, Núm. 3, pp. 1015-1028

  8. Unlocking the potential of 1,4-naphthoquinones: A comprehensive review of their anticancer properties

    European Journal of Medicinal Chemistry, Vol. 268

2023

  1. Exploring Novel Drug Combinations: The Therapeutic Potential of Selanyl Derivatives for Leishmania Treatment

    Molecules, Vol. 28, Núm. 15

  2. First Generation of Antioxidant Precursors for Bioisosteric Se-NSAIDs: Design, Synthesis, and In Vitro and In Vivo Anticancer Evaluation

    Antioxidants, Vol. 12, Núm. 9

  3. From Natural Sources to Synthetic Derivatives: The Allyl Motif as a Powerful Tool for Fragment-Based Design in Cancer Treatment

    Journal of Medicinal Chemistry, Vol. 66, Núm. 6, pp. 3703-3731

  4. Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity

    Bioorganic Chemistry, Vol. 138

  5. Novel Acylselenourea Derivatives: Dual Molecules with Anticancer and Radical Scavenging Activity

    Antioxidants, Vol. 12, Núm. 7

  6. Preparation of Selenium-Based Drug-Modified Polymeric Ligand-Functionalised Fe3O4 Nanoparticles as Multimodal Drug Carrier and Magnetic Hyperthermia Inductor

    Pharmaceuticals, Vol. 16, Núm. 7

  7. Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitors

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 38, Núm. 1

  8. Seleno-Analogs of Scaffolds Resembling Natural Products a Novel Warhead toward Dual Compounds

    Antioxidants, Vol. 12, Núm. 1

  9. Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases

    European Journal of Medicinal Chemistry, Vol. 246

2022

  1. Design, synthesis and anticancer evaluation of novel Se-NSAID hybrid molecules: Identification of a Se-indomethacin analog as a potential therapeutic for breast cancer

    European Journal of Medicinal Chemistry, Vol. 244

  2. Encapsulation of MSCs and GDNF in an Injectable Nanoreinforced Supramolecular Hydrogel for Brain Tissue Engineering

    Biomacromolecules, Vol. 23, Núm. 11, pp. 4629-4644

  3. Metal-based compounds containing selenium: An appealing approach towards novel therapeutic drugs with anticancer and antimicrobial effects

    European Journal of Medicinal Chemistry, Vol. 244